How do you define value in healthcare? MIT Sloan BioInnovations Conference to discuss how value is created, assessed and translated to improve healthcare practice

CAMBRIDGE, Mass., Feb. 10, 2015 /PRNewswire-USNewswire/ -- How can we partner and collaborate in new ways to find new cures for disease? How can we take patient data and transparency to improve outcomes for everyone? How can we utilize healthcare technologies to change the shape of the industry?

On Friday, February 20, 2015, the MIT Sloan BioInnovations Conference will bring together industry, academic and policy leaders to address trends and new approaches to redefine value in healthcare. The conference will be held at the Boston Marriott Cambridge hotel in Kendall Square.

Slated keynote speakers are:

• Dr. Mark Fishman, President, Novartis Institutes for BioMedical Research
• Dr. Gary Kelloff, Special Advisor, National Cancer Institute; Special Advisor, National Institutes of Health
• Dr. John Halamka, Chief Information Officer, Beth Israel Deaconess Medical Center; Chief Information Officer & Dean of Technology, Harvard Medical School
• Jamie Heywood, Co-Founder & Chairman, PatientsLikeMe

The conference features opening remarks by Neel Shah, MD, founder and executive director of Costs of Care and closing remarks by Andrew Lo, Charles E. and Susan T. Harris Professor of Finance at the MIT Sloan School of Management.

Four panels will focus on:

Trends in Healthcare Payment Models: Accountable Care Organizations
In an effort to improve patient outcomes while addressing rapidly rising healthcare costs, the Affordable Care Act encouraged the formation of Accountable Care Organizations (ACOs). With a number of uncertainties remaining around the ultimate role of ACOs, this panel will investigate current ACO models and discuss the potential future impact of these organizations across stakeholders.

Big Data, Policy, and Personalized Medicine
Pharmaceutical industry and academic experts, payers, and providers are now analyzing big data with state-of-the-art predictive modeling and simulation techniques. With the exciting movement of personalized medicine, there exists now the incredible opportunity to get even closer to exquisite precision in disease diagnosis and treatment. This panel will bring together thought leaders from across the field to explore big data's full potential, and its application to the field of personalized medicine.

The Future of Specialty Drug Pricing & Reimbursement
This panel will discuss the state of specialty drug pricing and the numerous challenges facing the industry today. Topics will include: trends and experiments in payer management of specialty drugs, the pressures associated with a buy-and-bill business model, 340B drug pricing, payer's influence on biopharmaceutical R&D, and more. The panel consists of key stakeholders involved in pricing and reimbursement decisions, including representatives from the biopharmaceutical industry, insurance companies, and physician groups.

Designing, Implementing, and Commercializing Devices in Emerging Markets
With a panel of experts from both academia and industry, they will discuss the various design, financing, and infrastructure challenges that organizations have tackled in order to successfully introduce medical technologies into the developing world.

For more information and to register, please visit: http://web.mit.edu/sloanhcc/bioinnovations/2015/

Follow along on Twitter @MITBioInnov and using #mitsloanbioinnovations and #valueinhealthcare.

About the MIT Sloan BioInnovations Conference
The MIT Sloan BioInnovations conference has established itself as an important forum for leaders in industry, academia, and policy to discuss current issues and future innovations in the dynamic area of healthcare, from healthcare in emerging markets to new drug technologies.

For more information, contact:

Logo - http://photos.prnewswire.com/prnh/20141117/158975LOGO

SOURCE MIT Sloan School of Management

Related Links

http://www.mitsloan.mit.edu